Also known as: Ipam
Molecular Weight
711.85 Da
Half-Life
2 hours
Administration
Subcutaneous injection
Longevity Score
8/10
A highly selective pentapeptide growth hormone secretagogue that mimics GHRP-6 but with superior selectivity. Stimulates GH release via ghrelin receptor pathway without releasing ACTH, cortisol, or prolactin even at high doses.
beginner
100mcg before bed
intermediate
200mcg before bed
advanced
300mcg before bed
athlete
200mcg before bed (combine with CJC-1295)
Frequency: Daily (before bed) · Duration: 8–16 weeks continuous; cycle 5 days on / 2 days off for extended use
Week 1-2
Improved sleep, recovery
Week 3-4
Fat loss begins, muscle fullness
Week 5-8
Noticeable body recomposition
Long Term
Sustained GH optimization without hormonal disruption
Ipamorelin GH release study (1998)
Demonstrated selective GH release without affecting cortisol or prolactin
DOI: 10.1210/endo.139.11.6263Explore more peptides in this category
View All Growth Hormone Peptides →Research Disclaimer: This information is compiled from published research and is provided for educational purposes only. Peptides discussed here are classified as research chemicals in most jurisdictions and are not FDA-approved for human use unless otherwise noted. Consult a qualified healthcare provider before starting any protocol.